Watson Bioproducts Supported by Gates Foundation To Accelerate Research and Development of 9-Price HPV Vaccine
-
Last Update: 2020-06-01
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Watson Bio said the aim of the agreement is to support Shanghai Zerun's development of a safe, effective and low-cost 9-price HPV vaccine, which will be pre-certified by the WHO to supply the vaccine cheaply to low-income countries funded by international organizations to improve its healthIt is reported that Shanghai Zerun's 9-price HPV vaccine is currently undergoing Phase 1 clinical trialsShanghai Zerun Biotech Co., Ltdwas established in 2003, focusing on research and development and industrialization of new recombinant human vaccine productsZerun Bio completed its integration with Watson Bio at the end of 2012 as its controlling subsidiaryReference Source:, Yunnan Watson Biotechnology Co., Ltdannouncement on the signing of a 9-price HPV vaccine funding agreement with the Bill and Melinda Gates Foundation, a subsidiary of Shanghai Zerun Biotech Co., Ltd.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
